주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-28 16:29 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
Policy
목록
(
총 :
642 )
기사목록 보기 형태
제목형
요약형
포토형
Doctors’ group opposes lowering Covid-19 quarantine grade
Song Soo-youn
2023.08.04 16:43
Spinraza’s reimbursement depends on proving continuous motor function
Kim Eun-young
2023.08.03 14:55
KDCA chief vows ‘caution in Covid-19’s transit to 4th-grade infectious disease’
Kim Eun-young
2023.08.02 16:30
Ban on fetal sex identification goes to Constitutional Court for 2nd time
Koh Jung Min
2023.08.01 16:46
Korea discarded ₩800 billion worth of Covid-19 vaccines: report
Lee Han-soo
2023.08.01 13:45
Stock prices of Covid-19 diagnostic kit makers jump as infection resurges
Lee Han-soo
2023.07.31 14:26
‘60,000 illegal prescriptions of narcotics made during temporary telemedicine period’
Kwak Sung-sun
2023.07.28 15:58
Health ministry approves study for NK cell + chemotherapy to treat SCLC
Kwak Sung-sun
2023.07.28 15:34
Korea BIO welcomes tax law revision to make biopharmaceuticals national strategic tech
Marianne Chang
2023.07.28 14:27
NHIS head points to excessive CTs and MRIs; vows to compensate surgical costs
Kim Eun-young
2023.07.28 11:49
Drug regulator aims to establish international harmonization organ. Why?
Kim Chan-hyuk
2023.07.26 13:44
Korea has fewer doctors and medical students, but healthcare use is on top, OECD says
Kwak Sung-sun
2023.07.25 16:15
처음
이전
이전
이전
21
22
23
24
25
26
27
28
29
30
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기